Biodesix offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue analysis.
- Sector(s): Healthcare
- Industry: Diagnostics & Research
- Full Time Employees: 200
- http://www.biodesix.com
Biodesix priced 4 mln share IPO at $18.00 per shaer, in-line with the expected range of $17-19
No comments:
Post a Comment